Log in to save to my catalogue

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4eb4de4b04e4f148708514ed969a051

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

About this item

Full title

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2019-02, Vol.8 (3), p.204

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Panax ginseng and Panax notoginseng, two well-known medical plants with economic value, have a long history of use for managing various diseases in Asian countries. Accumulating clinical and experimental evidence suggests that notoginsenosides and ginsenosides, which are the major bioactive components of the plants, have a variety of beneficial eff...

Alternative Titles

Full title

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e4eb4de4b04e4f148708514ed969a051

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4eb4de4b04e4f148708514ed969a051

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells8030204

How to access this item